Technicals

Geron (GERN) Enters Oversold Territory – Tale of the Tape

Geron Corporation’s ( GERN ) share price has entered into oversold territory with an RSI value of 28.7. The Zacks Consensus Estimate for Geron for the full year period has remained flat over the past two months at -29 cents per share. Currently, Geron has a Zacks Rank #2 (Buy), suggesting that now might be a good time to get in on ( GERN ) after its recent drop. […]

Technicals

Why Altisource Residential (RESI) Could Be Positioned for a Surge? – Tale of the Tape

Altisource Residential Corporation ( RESI ) is a real estate developer and it could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is seeing solid activity on the earnings estimate revision front as well. These positive earnings estimate revisions suggest that analysts are becoming more optimistic on RESI’s earnings for the coming quarter and year […]

Technicals

Panera Bread (PNRA) in Focus: Stock Tumbles 8.5% – Tale of the Tape

Panera Bread Company ( PNRA ) saw a big move in the last trading session, as the company’s shares fell by over 8% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading below the volatile price range of $180.92 to $190.38 in the past one-month time frame. […]

Technicals

Is Federated National (FNHC) Stock a Solid Choice Right Now? – Tale of the Tape

One stock that might be an intriguing choice for investors right now is Federated National Holding Company ( FNHC ). This is because this security in the Property & Casualty Insurance space is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective. This is important because, often times, a rising tide will lift all boats in an industry, as there can be broad trends taking place in a segment that are boosting securities across the board […]

FDA Approval

Oramed Pharmaceuticals Announces First Patient Enrolled in a US Phase 2a Trial for ORMD-0801 in Treatment of Type 1 Diabetes

Oramed Pharmaceuticals Announces First Patient Enrolled in a US Phase 2a Trial for ORMD-0801 in Treatment of Type 1 Diabetes PR Newswire JERUSALEM, March 27, 2014 JERUSALEM , March 27, 2014 /PRNewswire/ — Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) ( http://www.oramed.com ), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that the first patient has been enrolled in its U.S. Phase 2a trial for its orally ingestible insulin capsule, ORMD-0801, in the treatment of type 1 diabetes (T1DM) […]

Mergers & Acquisitions

IQNavigator Provides Progress Update on Integration of ProcureStaff Technologies Acquisition

IQNavigator Provides Progress Update on Integration of ProcureStaff Technologies Acquisition Growing Number of Customers Planning to Migrate from ProcureStaff VMS to IQNavigator VMS Platform to Leverage Trusted Resources and Speed-to-Value Benefits PR Newswire DENVER, March 27, 2014 DENVER , March 27, 2014 /PRNewswire/ — IQNavigator, the leading provider of non-employee workforce management solutions to Global 2000 companies, today provided a progress update on its integration of ProcureStaff Technologies into the organization. Since the January 8, 2014 acquisition of the ProcureStaff vendor managed software solutions and related assets from Volt Information Sciences, the company has successfully completed a long list of acquisition integration tasks to ensure a seamless, business-as-usual environment for its newest customers and employees. […]